Homocysteine and methylenetetrahydrofolate reductase C677T and A1298C polymorphisms in Tunisian patients with severe coronary artery disease

Journal of Thrombosis and Thrombolysis

Volumn 27, Issue 2, 2009, Pages 191-197

  Ghazouani, Lakhdar ^a   Abboud, Nesrine ^a   Mtiraoui, Nabil ^a   Zammiti, Walid ^a   Addad, Faouzi ^b   Amin, Haitham ^c   Almawi, Wassim Y ^b   Mahjoub, Touhami ^a  

^a UNIVERSITY OF MONASTIR   (Tunisia)

^b FATTOUMA BOURGUIBA UNIVERSITY HOSPITAL   (Tunisia)

^c ARABIAN GULF UNIVERSITY   (Bahrain)

Author keywords

Coronary artery disease; Homocysteine; Mehylenetetrahydrofolate Reductase; Mutation

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ADENINE; BIOLOGICAL MARKER; CYTOSINE; HOMOCYSTEINE; THYMINE;

ADULT; AFRICA; ALLELE; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; GENE FREQUENCY; GENE LOCATION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; FEMALE; GENE FREQUENCY; HAPLOTYPES; HOMOCYSTEINE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; MUTATION, MISSENSE; POLYMORPHISM, SINGLE NUCLEOTIDE; TUNISIA;

EID: 62149125817     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-008-0194-1     Document Type: Article

References (32)

1. Welch GN, Loscalzo J (1998) Homocysteine and atherothrombosis. N EngI J Med 338:1042-1050
2. Lentz SR (2005) Mechanisms of homocysteine-induced atherothrombosis. J Thromb Haemost 3:1646-1654
3. Quere I, Gris JC, Dauzat M (2005) Homocysteine and venous thrombosis. Semin Vasc Med 5:183-189
4. D'Angelo A, Mazzola G, Fermo I (2003) Gene-gene and gene-environment interactions in mild hyperhomocysteinemia. Pathophysiol Haemost Thromb 33:337-341
5. Balasa VV, Gruppo RA, Gartside PS, Kalinyak KA (1999) Correlation of the C677T MTHFR genotype with homocysteine levels in children with sickle cell disease. J Pediatr Hematol Oncol 21:397-400
6. Friedman G, Goldschmidt N, Friedlander Y, Ben-Yehuda A, Selhub J, Babaey S, Mendel M, Kidron M, Bar-On H (1999) A common mutation A1298C in human methylenetetrahydrofolate reductase gene: Association with plasma total homocysteine and folate concentrations. J Nutr 129:1656-1661
7. Friso S, Girelli D, Trabetti E, Stranieri C, Olivieri O, Tinazzi E, Martinelli N, Faccini G, Pignatti PF, Corrocher R (2002) A1298C methylenetetrahydrofolate reductase mutation and coronary artery disease: Relationships with C677T polymorphism and homocysteine/folate metabolism. Clin Exp Med 2:7-12
8. Chango A, Boisson F, Barbé F, Quilliot D, Droesch S, Pfister M, Fillon-Emery N, Lambert D, Frémont S, Rosenblatt DS, Nicolas JP (2000) The effect of 677C→T and 1298A→C mutations on plasma homocysteine and 5,10-methylenetetrahydrofolate reductase activity in healthy subjects. Br J Nutr 83:593-596
9. Schreiner PJ, Wu KK, Malinow MR, Stinson VL, Szklo M, Nieto FJ, Heiss G (2002) Hyperhomocyst[e]inemia and hemostatic factors: The atherosclerosis risk in communities study. Ann Epidemiol 12:228-236
10. Bennouar N, Allami A, Azeddoug H, Bendris A, Laraqui A, El Jaffali A, El Kadiri N, Benzidia R, Benomar A, Fellat S, Benomar M (2007) Thermolabile methylenetetrahydro-folate reductase C677T polymorphism and homocysteine are risk factors for coronary artery disease in Moroccan population. J Biomed Biotechnol 2007(1):80687
11. Kerkeni M, Addad F, Chauffert M, Myara A, Gerhardt M, Chevenne D, Trivin F, Farhat MB, Miled A, Maaroufi K (2006) Hyperhomocysteinaemia, methylenetetrahydrofolate reductase polymorphism and risk of coronary artery disease. Ann Clin Biochem 43:200-206
12. Klerk M, Verhoef P, Clarke R, Blom HJ, Kok FJ, Schouten EG (2002) MTHFR Studies Collaboration Group. MTHFR 677C→T polymorphism and risk of coronary heart disease: A meta-analysis. JAMA 288:2023-2031
13. Huh HJ, Chi HS, Shim EH, Jang S, Park CJ (2006) Gene-nutrition interactions in coronary artery disease: Correlation between the MTHFR C677T polymorphism and folate and homocysteine status in a Korean population. Thromb Res 117:501-506
14. Deloughery TG, Evans A, Sadeghi A, McWilliams J, Henner WD, Taylor LM Jr, Press RD (1996) Common mutation in methylenetetrahydrofolate reductase. Correlation with homocysteine metabolism and late-onset vascular disease. Circulation 94:3074-3078
15. Koch W, Ndrepepa G, Mehilli J, Braun S, Burghartz M, Lengnick H, Kölling K, Schömig A, Kastrati A (2003) Homocysteine status and polymorphisms of methylenetetrahydrofolate reductase are not associated with restenosis after stenting in coronary arteries. Arterioscler Thromb Vasc Biol 23:2229-2234
16. Gueant-Rodriguez RM, Juilliere Y, Candito M, Adjalla CE, Gibelin P, Herbeth B, Van Obberghen E, Gueant JL (2005) Association of MTRRA66G polymorphism (but not of MTHFR C677T and A1298C, MTRA2756G, TCN C776G) with homocysteine and coronary artery disease in the French population. Thromb Haemost 94:510-515
17. Laraqui A, Allami A, Carrie A, Raisonnier A, Coiffard AS, Benkouka F, Bendriss A, Benjouad A, Bennouar N, El Kadiri N, Benomar A, Fellat S, Benomar M (2007) Relation between plasma homocysteine, gene polymorphisms of homocysteine metabolism-related enzymes, and angiographically proven coronary artery disease. Eur J Intern Med 18:474-483
18. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP (1995) A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111-113
19. van der Put NM, Gabreels R, Stevens EM, Smeitink JA, Trijbels FJ, Eskes TK, van den Heuvel LP, Blom HJ (1998) A second common mutation in the methylenetetrahydrofolate reductase gene: An additional risk factor for neural-tube defects? Am J Hum Genet 62:1044-1051
20. Hawkins NM, Dunn FG (2006) The management of hypertension in ischaemic heart disease. Curr Opin Cardiol 21:273-278
21. Manrique CM, Lastra G, Palmer J, Stump CS, Sowers JR (2006) Hypertension - a treatable component of the cardiometabolic syndrome: Challenges for the primary care physician. J Clin Hypertens (Greenwich) 8(1 Suppl 1):12-20
22. DeFaria Yeh D, Freeman MW, Meigs JB, Grant RW (2007) Risk factors for coronary artery disease in patients with elevated high-density lipoprotein cholesterol. Am J Cardiol 99:1-4
23. Chwatko G, Jakubowski H (2005) Urinary excretion of homocysteine-thiolactone in humans. Clin Chem 51:408-415
24. van Guldener C, Stehouwer CD (2005) Homocysteine and methionine metabolism in renal failure. Semin Vasc Med 5:201-208
25. Kolling K, Ndrepepa G, Koch W, Braun S, Mehilli J, Schomig A, Kastrati A (2004) Methylenetetrahydrofolate reductase gene C677T and A1298C polymorphisms, plasma homocysteine, folate, and vitamin B12 levels and the extent of coronary artery disease. Am J Cardiol 93:1201-1206
26. Yilmaz H, Isbir S, Agachan B, Ergen A, Farsak B, Isbir T (2006) C677T mutation of methylenetetrahydrofolate reductase gene and serum homocysteine levels in Turkish patients with coronary artery disease. Cell Biochem Funct 24:87-90
27. Guerzoni AR, Pavarino-Bertelli EC, Godoy MF, Graca CR, Biselli PM, Souza DR, Bertollo EM (2007) Methylenetetrahydrofolate reductase gene polymorphism and its association with coronary artery disease. Sao Paulo Med J 125:4-8
28. Brilakis ES, Berger PB, Ballman KV, Rozen R (2003) Methylenetetrahydrofolate reductase (MTHFR) 677C > T and methionine synthase reductase (MTRR) 66A > G polymorphisms: Association with serum homocysteine and angiographic coronary artery disease in the era of flour products fortified with folic acid. Atherosclerosis 168:315-322
29. Garcia-Pinilla JM, Espinosa-Caliani S, Jimenez-Navarro M, Gomez-Doblas JJ, Cabrera-Bueno F, Reyes-Engel A, de Teresa-Galvan E (2007) Influence of 677 C→T polymorphism of methylenetetrahydrofolate reductase on medium-term prognosis after acute coronary syndromes. Tex Heart Inst J 34:142-147
30. Szczeklik A, Sanak M, Jankowski M, Dropinski J, Czachor R, Musial J, Axenti I, Twardowska M, Brzostek T, Tendera M (2001) Mutation A1298C of methylenetetrahydrofolate reductase: Risk for early coronary disease not associated with hyperhomocysteinemia. Am J Med Genet 101:36-39
31. Dhar M, Bellevue R, Brar S, Carmel R (2004) Mild hyperhomocysteinemia in adult patients with sickle cell disease: A common finding unrelated to folate and cobalamin status. Am J Hematol 76:114-120
32. Golbahar J, Fathi Z, Tamadon M (2005) Distribution of 5,10-methylenetetrahydrofolate reductase (C667T) polymorphism and its association with red blood cell 5-methyltetrahydrofolate in the healthy Iranians. Clin Nutr 24:83-87